Fig. 1
Descriptive meta-analysis from the related literature of the available amyloid-, tau-, and neuroinflammation-PET findings in proteinopathies. Color gradients index magnitude of alteration. Abbreviations: MSA, multiple system atrophy; PD, Parkinson’s disease; PDD, Parkinson’s disease and dementia; DLB, dementia with Lewy bodies; CAA, cerebral amyloid angiopathy; DS, Down’s syndrome; AD, Alzheimer’s disease; CTE, chronic traumatic encephalopathy; CBD, corticobasal degeneration; PSP, progressive supranuclear palsy; FT-tau, frontotemporal lobar degeneration due to tau pathology; FT-tdp, frontotemporal lobar degeneration due to TDP-43 pathology; ALS, amyotrophic lateral sclerosis; FT-fus, frontotemporal lobar degeneration due to FUS pathology; GSS, Gerstmann-Straussler-Scheinker disease; CJD, Creutzfeldt-Jakob disease; FFI, fatal familial insomnia; TDP, TAR DNA-binding protein 43; PET,…
